申请人:Golding Bernard
公开号:US20110263850A1
公开(公告)日:2011-10-27
The present invention relates to a novel process for producing quinazoline compounds which are useful in therapy. More specifically, the compounds produced by the process of the invention are useful in the treatment of a number of cardiovascular diseases. The process of the invention provides 6,7-dichloro-1,5- dihydroimidazo [2,1 -b] quinazolin 2 (3H)-one, more commonly known as anagrelide and its analogues in a clean and efficient manner.
本发明涉及一种新型生产喹唑啉化合物的方法,这些化合物在治疗方面非常有用。更具体地说,本发明所生产的化合物在治疗多种心血管疾病方面非常有用。本发明的方法以一种清洁高效的方式提供6,7-二氯-1,5-二氢咪唑[2,1-b]喹唑啉-2(3H)-酮,更常被称为阿那格雷利德及其类似物。